ALLIANCEBERNSTEIN L.P. - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 86 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.39 and the average weighting 0.6%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$5,626,801
+34.5%
261,347
+68.3%
0.00%
+100.0%
Q1 2024$4,182,273
+82.4%
155,244
+102.9%
0.00%0.0%
Q4 2023$2,293,005
-11.6%
76,510
-39.6%
0.00%0.0%
Q3 2023$2,594,075
+5.4%
126,602
+2.2%
0.00%0.0%
Q2 2023$2,462,092
-17.9%
123,910
-29.2%
0.00%0.0%
Q1 2023$2,998,110
+213.3%
175,021
+257.9%
0.00%
Q4 2022$956,973
+22.7%
48,9000.0%0.00%
Q3 2022$780,000
-65.6%
48,900
-70.3%
0.00%
-100.0%
Q2 2022$2,269,000
+15.5%
164,889
+33.1%
0.00%0.0%
Q1 2022$1,965,000
-37.4%
123,900
-13.8%
0.00%0.0%
Q4 2021$3,139,000
-29.2%
143,812
-3.0%
0.00%
-50.0%
Q3 2021$4,432,000
+82.5%
148,272
+170.3%
0.00%
+100.0%
Q2 2021$2,429,000
+12.2%
54,847
+12.4%
0.00%0.0%
Q1 2021$2,165,000
-17.7%
48,800
+1.7%
0.00%0.0%
Q4 2020$2,632,000
+229.0%
48,000
+37.1%
0.00%
Q3 2020$800,000
+5.0%
35,000
-3.8%
0.00%
Q2 2020$762,000
+56.1%
36,400
+4.0%
0.00%
Q1 2020$488,000
-42.7%
35,000
-6.4%
0.00%
Q4 2019$851,000
+76.9%
37,400
-9.4%
0.00%
Q3 2019$481,000
+4.1%
41,300
+34.1%
0.00%
Q2 2019$462,000
+9.0%
30,800
+27.3%
0.00%
Q1 2019$424,000
+41.8%
24,200
+19.8%
0.00%
Q4 2018$299,000
-19.6%
20,200
+33.8%
0.00%
Q3 2018$372,000
-68.4%
15,100
-74.8%
0.00%
-100.0%
Q2 2018$1,176,00059,9000.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 2,965,485$162,627,00024.83%
RTW INVESTMENTS, LP 17,060,211$935,582,00015.70%
Copernicus Capital Management, LLC 8,000$439,0006.84%
GREAT POINT PARTNERS LLC 700,000$38,388,0006.24%
Ghost Tree Capital, LLC 500,000$27,420,0006.11%
Affinity Asset Advisors, LLC 105,000$5,758,0003.05%
Boxer Capital, LLC 1,466,051$80,398,0002.58%
HIGHLINE CAPITAL MANAGEMENT, L.P. 77,400$4,245,0002.08%
Perceptive Advisors 3,396,867$186,284,0002.00%
Cormorant Asset Management, LP 1,368,550$75,051,0001.79%
View complete list of ROCKET PHARMACEUTICALS INC shareholders